Publikasjoner - Legemiddelbivirkninger

Avdeling for klinisk farmakologi

• Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O. Selective serotonin reuptake inhibitors, antipsychotics and metabolic risk factors in schizophrenia and bipolar disorder. Eur Psychiatry 2018; 48: 71-78.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29331603
• Mauseth SA, Skurtveit S, Skovlund E, Langhammer A, Spigset O. Medication use and association with urinary incontinence in women: Data from the Norwegian prescription database and the HUNT study. Neurourol Urodyn 2018; 37: 1448-57.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29336066
• Jönsson AK, Schill J, Olsson H, Spigset O, Hägg S. Venous thromboembolism during treatment with antipsychotics: a review of current evidence. CNS Drugs 2018; 32: 47-64.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29423659
• Hjelle LV, Gundersen POM, Hellesnes R, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Bremnes RM, Haugnes HS. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.  Acta Oncol 2018; 57: 1392-1400.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29775128
• Hansen CC, Ljung H, Brodtkorb E, Reimers A. Aggressive behavior induced by antiepileptic drugs. Behav Neurol 2018; 2064027.
https://www.ncbi.nlm.nih.gov/pubmed/?term=30581496
• Smith RL, Haslemo T, Andreassen OA, Eliasson E, Dahl M-L, Spigset, O, Molden E. Serum concentration of N-desmethylclozapine is significantly correlated with neutrophil granulocyte levels in schizophrenia patients. CNS Drugs 2017; 31:991-7.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28948574
• Skalleberg JR; Popova O; Fosså SD; Småstuen MC; Osnes T; Gundersen POM; Bunne BIM. Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer. Gynecol Oncol 2017; 145: 148-53.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28202195
• Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O. Metabolic abnormalities related to treatment with selective serotonin reuptake inhibitors in patients with schizophrenia or bipolar disorder. J Clin Psychopharmacol 2016; 36: 615-20.
https://www.ncbi.nlm.nih.gov/pubmed/27749681  
• Hjelle LV, Bremnes RM, Gundersen PO, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Haugnes HS. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors. Urol Oncol. 2016; 34: 487.e13-487.e20.
https://www.ncbi.nlm.nih.gov/pubmed/27523611  
• Hagen NT, Spigset O. Sulfaallergi – hvilke legemidler må pasienten unngå på grunn av risiko for kryssreaksjon? Tidsskr Nor Legeforen 2016; 136: 915-8.
http://tidsskriftet.no/2016/06/klinisk-oversikt/sulfaallergi-hvilke-legemidler-ma-pasienten-unnga  
• Bjørner T, Anwar T, Brede WR, Hemmersbach P, Slørdal L: En mann med endret utseende. Tidsskr Nor Legeforen 2015; 135: 243-5.
http://tidsskriftet.no/article/3288936
• Møllersen MV, Norgård H, Spigset O, Slørdal L. Hjerte, smerte – kardiovaskulær sikkerhet og ikke-steroide antiinflammatoriske legemidler. Tidsskr Nor Legeforen 2015; 135: 542-6.
http://tidsskriftet.no/article/3308286
• Fjermeros K, Werner MCF, Harg P, Samdal H, Slørdal L, Spigset O. Melding av legemiddelbivirkninger fra pasienter i Norge 2010-2013. Tidsskr Nor Legeforen 2015; 135: 536-40.
http://tidsskriftet.no/article/3307244  

Sist oppdatert 05.09.2024